What is the role of profibrogenic and proinflammatory factors in developing atrial fibrillation associated with metabolic syndrome components?

QR Code

What is the role of profibrogenic and proinflammatory factors in developing atrial fibrillation associated with metabolic syndrome components?

Aim. To determine the concentration of blood fibrotic and inflammatory biomarkers in patients with atrial fibrillation (AF) associated with metabolic syndrome (MS) components.Material and methods. The study included 646 patients aged 35-65 years: patients with AF and MS (n=142), those with AF and wi...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. A. Ionin, E. I. Barashkova, V. A. Pavlova, G. I. Borisov, K. A. Averchenko, E. L. Zaslavskaya, E. I. Baranova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2021-12-01
Series:	Российский кардиологический журнал
Subjects:	aldosterone galectin-3 tgf-beta1 ctgf ct-1 il-6 atrial fibrillation metabolic syndrome
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4752
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular mechanisms of left atrial fibrosis development in patients with atrial fibrillation and metabolic syndrome: what biomarkers should be used in clinical practice?
by: V. A. Ionin, et al.
Published: (2021-08-01)

THE ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 AND GALECTIN-3 IN FORMATION OF THE LEFT ATRIUM FIBROSIS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: E. L. Zaslavskaya, et al.
Published: (2018-03-01)

GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: V. A. lonin, et al.
Published: (2015-04-01)

Neuregulin-1β, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients
by: K. A. Zhbanov, et al.
Published: (2022-11-01)

Biomarkers of fibrosis and inflammation and the risk of arrhythmia recurrence after elective electrical cardioversion in patients with atrial fibrillation and metabolic syndrome
by: E. I. Barashkova, et al.
Published: (2024-06-01)

Adenosine A<sub>2B</sub> Receptor Antagonism Interferes with TGF-β Cellular Signaling Through SMAD2/-3 and p65-Nf-κB in Podocytes and Protects from Phenotypical Transformation in Experimental Diabetic Glomerulopathy
by: Ignacio Arias, et al.
Published: (2025-06-01)

Galectins: a potential pharmacological target
by: V. A. Serebryakova, et al.
Published: (2024-10-01)

INFLAMMASOME NLRP1 DISTINCTIVE FEATURES IN ATOPIC CONDITIONS
by: Денис Сергеевич Загрешенко, et al.
Published: (2023-08-01)

Cytokine profile in the liver during its diffuse damage and Heptor introduction
by: O. V. Alpidovskaya
Published: (2025-03-01)

ROLE OF PRO- AND ANTIANGIOGENIC FACTORS IN PLACENTAL DEVELOPMENT
by: D. I. Sokolov, et al.
Published: (2014-07-01)

GENETIC MARKERS OF MYOCARDIAL FIBROSIS: OPPORTUNITY TO PREDICT ADVERSE OUTCOMES IN AORTIC STENOSIS
by: Т. A. Tipteva, et al.
Published: (2018-03-01)

A Dual Role of HGF-ERK Signaling in IL6/HGF-induced Hepatocyte ProliferationSummary
by: Jingwei Zhang, et al.
Published: (2025-01-01)

Galectin-1 and Galectin-3 expression in colon cancer and its correlation with tumor invasion, differentiation, and metastatic spread
by: Yu. V. Kolobovnikova, et al.
Published: (2021-12-01)

Influence of proinflammatory cytokines on membrane rigidity and morphofunctional state of circulating neutrophils in ovarian tumors
by: T. V. Abakumova, et al.
Published: (2022-03-01)

Galectins, antibodies to them and galectin-3 binding protein in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2025-03-01)

Diagnostic significance of TGF-β1 in kidney recipients with graft dysfunction
by: О. P. Shevchenko, et al.
Published: (2024-01-01)

Galectin-3: role in the formation of various hemodynamic phenotypes of heart failure and interaction with some neurohumoral factors
by: A. K. Kurbonov, et al.
Published: (2020-08-01)

The role of galectin-1 in the T-lymphocytes homeostasis
by: V. D. Yakushina, et al.
Published: (2011-12-01)

Blood aldosterone level in various types of atrial fibrillation
by: N. T. Vatutin, et al.
Published: (2016-02-01)

The Association of Serum Level of TGF‐β1 and Clinical Manifestations in Sickle Cell Anemia: A Case‐Control Study
by: Fatemeh Bakhshipour, et al.
Published: (2025-07-01)

Immunohistochemical Expression of P16 Protein and TGF β1 in Mice Liver Exposed to Fumonisin B1
by: Mohammed et al.
Published: (2020-05-01)

Evaluation of mediators of fibrosis and angiogenesis in the blood serum of premature infants with bronchopulmonary dysplasia
by: E. L. Semikina, et al.
Published: (2023-06-01)

THE USE OF MINERALOCORTICOID RECEPTOR ANTAGONISTS IN THE PRE VENTION OF ATRIAL FIBRILLATION
by: N. T. Vatutin, et al.
Published: (2019-07-01)

Immunohistochemical expression of IL-1β, IL-6, and NF-κβ in fibroids
by: Mateusz de Mezer, et al.
Published: (2025-07-01)

Role of TGF-?1 in Urinary Bladder Carcinoma
by: Baghdad Science Journal
Published: (2014-12-01)

Imbalance of NK cell subpopulations and polymorphisms of proinflammatory cytokine genes in the pathogenesis of atherosclerosis
by: A. R. Tuguz, et al.
Published: (2022-03-01)

New aspects of immunopathogenesis of retinopathy of prematurity: the role of TGF-β1 and IGF-II in pathological vascularization of the retina
by: L. A. Katargina, et al.
Published: (2018-10-01)

SNP genes of immune response mediators and predisposition to development of socially significant diseases
by: E. A. Tatarkova, et al.
Published: (2022-07-01)

GALECTIN-1 AND ITS ROLE IN DEVELOPMENT OF INNATE AND ADAPTIVE IMMUNITY
by: V. D. Yakushina, et al.
Published: (2014-07-01)

С(-344)Т polymorphism of aldosterone synthase gene, risk of metabolic syndrome, and atrial fibrillation risk for inhabitants of the Northwest regions of Russia
by: I. Ma, et al.
Published: (2016-06-01)

Pathogenetic significance of transforming growth factor β1 in patients with colorectal cancer
by: A. V. Chetveryakov, et al.
Published: (2022-10-01)

URINARY EXCRETION OF IL-1β, MONOCYTE CHEMOATTRACTANT PROTEIN-1 AND TRANSFORMING GROWTH FACTOR-
by: G. R. Gazizova, et al.
Published: (2015-03-01)

Polymorphism of proinflammatory inerleukin genes in primary open-angle glaucoma
by: L. Yu. Barycheva, et al.
Published: (2024-01-01)

The Role of Serum Chitinase-3-Like 1 Protein (YKL-40) Level and its Correlation with Proinflammatory Cytokine in Patients with Rheumatoid Arthritis
by: Noor Ulhuda G. Mohammed, et al.
Published: (2022-10-01)

Myeloid TGF-β signaling shapes liver macrophage heterogeneity and metabolic liver disease pathogenesis
by: Ziyi Meng, et al.
Published: (2025-08-01)

Atrial fibrillation and CHA2DS2VASc score of 1 - is there a problem in clinical practice?
by: E. I. Baranova, et al.
Published: (2020-04-01)

Diagnostic and therapeutic potential of transforming growth factor beta 1 in solid organ transplantation: recent research findings
by: S. O. Sharapchenko, et al.
Published: (2023-07-01)

Lung cancer intravasation-on-a-chip: Visualization and machine learning-assisted automatic quantification
by: Christy Wing Tung Wong, et al.
Published: (2025-09-01)

Role of galectin 3 and epicardial fat thickness in the development of atrial fibrillation in patients with metabolic syndrome
by: V. A. Ionin, et al.
Published: (2015-03-01)

TRANSFORMING GROWTH FACTOR 1 AT LIVER TRANSPLANTATION
by: R. M. Kurabekova, et al.
Published: (2015-10-01)